Plain-English translation of NCT07477704 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a medication that helps lower high cholesterol, to see if giving it once a week is safe and effective. is already approved by the FDA to treat high cholesterol, but researchers want to learn more about how well the medication works when given weekly instead of other schedules. The study will compare different doses of the medication to find the best balance of safety and effectiveness.
Currently, people with high cholesterol have to manage their condition with different treatment options and schedules. Researchers want to see if this medication given weekly could be a simpler, more convenient way for adults to control their high cholesterol levels.
You would be randomly assigned to receive one of four different dose levels of the medication given as a weekly injection. Throughout the study, you would visit the clinic regularly so researchers can check how the medication is working, monitor your cholesterol levels, and watch for any side effects. The study will track how much medication is in your bloodstream over time and gather information about the safety and effectiveness of the treatment.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States